SCHEMBL1803333

SCHEMBL1803333

COCc1[c]cn(-c2ccccc2F)n1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
LMNA P02545 1/20 0.39
KCNN4 O15554 3/20 0.39
NOTUM Q6P988 1/20 0.36
ADORA1 P30542 1/20 0.35
ADORA3 P0DMS8 2/20 0.33
HSD17B10 Q99714 1/20 0.33
PDE10A Q9Y233 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 2/20 0.32
GAA P10253 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1906385 0.74 ADORA1 (0.42) ALDH1A1KCNN4NOTUMADORA1ADORA3
SCHEMBL28797994 0.70 ADORA1 (0.39) ALDH1A1SMN1; SMN2NPC1LMNAKCNN4
SCHEMBL1806117 0.68 NOTUM (0.46) ALDH1A1SMN1; SMN2LMNAKCNN4NOTUM
SCHEMBL1806825 0.67 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2NPC1LMNAKCNN4
SCHEMBL1807795 0.67 NOTUM (0.44) ALDH1A1SMN1; SMN2LMNANOTUMADORA1
SCHEMBL3626705 0.66 NOTUM (0.37) SMN1; SMN2KCNN4NOTUMADORA1ADORA3
SCHEMBL29514421 0.62 PKM (0.44) ALDH1A1SMN1; SMN2NPC1NOTUMADORA3
SCHEMBL22748471 0.62 PKM (0.44) ALDH1A1SMN1; SMN2NPC1NOTUMADORA3
SCHEMBL2902914 0.62 NOTUM (0.41) ALDH1A1NOTUMADORA1ADORA3RAB9A
SCHEMBL2820799 0.60 NOTUM (0.44) ALDH1A1KCNN4NOTUMADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501704-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
CN-102666550-A Spiropiperidine compounds as ORL-1 receptor antagonists LILLY CO ELI 2012-09-12 CN disclosed
WO-2011060217-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed